Ѫ˨ǰ״̬±êÖ¾Îï,markers on prethromboticstate
1)markers on prethromboticstateѪ˨ǰ״̬±êÖ¾Îï
Ó¢ÎĶ̾ä/Àý¾ä

1.Change and Significance of Markers to Prethrombotic State in Patients with Type 2 Diabetes RetinopathyѪ˨ǰ״̬±êÖ¾ÎïÔÚ2ÐÍÌÇÄò²¡ÊÓÍøĤ²¡±äÖеı仯¼°ÒâÒå
2.Study on the Relationship between the Endothelial Dysfunction and Platelet Activity in Preeclampsia and Prethrombotic State Markers;×ÓðïÇ°ÆÚ»¼ÕßѪ¹ÜÄÚƤËðÉ˼°ÑªÐ¡°å¼¤»îÓëÍâÖÜѪѪ˨ǰ״̬±êÖ¾ÎïÏà¹ØÐÔÑо¿
3.Changes of Plasma Prethrombotic State Related Molecular Markers Levels in Patients with HyperhomocysteinemiaHHcy»¼ÕßѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïµÄ±ä»¯
4.Change of molecular markers of prethrombotic state in children with Kawasaki disease´¨Æ鲡»¼¶ùѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïµÄ±ä»¯
5.The Prethrombotic State Indentification in Coronary Heart Disease¹ÚÐIJ¡»¼ÕßѪ˨ǰ״̬·Ö×Ó±êÖ¾Îï¼ì²â
6.Effect of Isodon.serra Kudo on the Markers of Prothrombotic State Pro-inflammatory State in Metabolic SyndromeϪ»Æ²Ý¶Ô´úл×ÛºÏÕ÷»¼ÕßѪ˨ǰ״̬¼°Ç°Ñ×ÐÔ״̬±êÖ¾ÎïµÄ×÷ÓÃ
7.Detection of Molecular Markers of Prethrombotic State on Blood-Stasis Syndrome of Cancer Patients and Its Clinical Significance¶ñÐÔÖ×ÁöѪðöÖ¤ÐÍѪ˨ǰ״̬·Ö×Ó±êÖ¾Îï²â¶¨¼°ÆäÒâÒå
8.Effects of Molecular Markers of Prethrombotic State on the Phlegm-stasis Syndrome of Hypertension Disease¸ßѪѹ²¡Ìµðö֤Ѫ˨ǰ״̬·Ö×Ó±êÖ¾Îï±ä»¯¼°ÒâÒå
9.The changes of markers to prethrombotics tate in patients with type 2 diabetes microangiopathyѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïÔÚ2ÐÍÌÇÄò²¡Î¢Ñª¹Ü²¡±äÖеı仯
10.The Changes of Molecular Markers of Prethrombotic State in Patients with Coronary Heart Disease and Its Clinical Significance;¹ÚÐIJ¡²¡ÈËѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïµÄ±ä»¯¼°ÁÙ´²ÒâÒå
11.Study on molecule marker of pro-thromb state with diabetic retinopathyÌÇÄò²¡ÊÓÍøĤ²¡±äѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïµÄÑо¿
12.Study on the Change of the Levels of Prethrombotic State Molecular Markers in Pregnancy Induced Hypertension Patients;ÈÑÉï¸ßѪѹ×ÛºÏÕ÷»¼ÕßÍâÖÜѪѪ˨ǰ״̬·Ö×Ó±êÖ¾Îïˮƽ±ä»¯µÄÑо¿
13.Study on the Makers of Thrombus and Platelet Activation in Patients of Hypertensive Disorder Complicating PregnacyÈÑÉïÆÚ¸ßѪѹ²¡»¼ÕßѪ˨±êÖ¾ÎPѪС°å»î»¯×´Ì¬Ñо¿
14.Test of some indexes about pre-thrombotic state in the patients with severe pneumoniaÖØÖ¢·ÎÑ×»¼ÕßѪ˨ǰ״̬ʵÑéÖ¸±êµÄ²â¶¨
15.Study of Nitric Oxide as Molecular Marker of Prestroke State in Hypertensive RatsÒ»Ñõ»¯µª×÷Ϊ¸ßѪѹ´óÊó×äÖÐǰ״̬·Ö×Ó±êÖ¾ÎïÑо¿
16.Study on the Serologic Markers of Early Stage of Pulmonary Thromboembolism;·ÎѪ˨˨ÈûÖ¢ÔçÆÚѪÇåѧ±êÖ¾ÎïµÄÑо¿
17.Exploratory Study on Thrombosis Markers for Acute Thrombotic Diseases¼±ÐÔѪ˨ÐÔ¼²²¡ÑªË¨±êÖ¾ÎïµÄ̽Ë÷ÐÔÑо¿
18.Morning blood pressure surge and prothrombotic stateÁ賿ѪѹÉý¸ßÓëѪ˨ǰ״̬¹Øϵ·ÖÎö
Ïà¹Ø¶Ì¾ä/Àý¾ä

prethrombotic state molecular markerѪ˨ǰ״̬·Ö×Ó±êÖ¾Îï
1.This study was aimed to investigate the dynamic changes of plasma prethrombotic state molecular marker levels during perioperation of patients and to provide laboratorial evidence for clinical diagnosis of these patients so as to take intervenient measure to high risk patients.±¾Ñо¿Ö¼ÔÚ¹Û²ìÊÖÊõ»¼ÕßΧÊõÆÚѪ½¬ÑªË¨Ç°×´Ì¬·Ö×Ó±êÖ¾ÎïµÄ¶¯Ì¬±ä»¯,ΪÁÙ´²ÅжÏѪ˨ǰ״̬¡¢¶Ô¸ßΣ»¼Õß²ÉÈ¡ÔçÆÚ¸ÉÔ¤´ëÊ©ÌṩʵÑéÒÀ¾Ý¡£
3)the markers of thrombosisѪ˨±êÖ¾Îï
1.Objective To examine the changes of d-dimer(D-D) and von Willebrand factor(vWF),the markers of thrombosis in peripheral blood,as well as the expression of P-selectin(CD62P) and CD63,and the markers of platelet activation before and after thrombolytic therapy in acute myocardial infarction(AMI),along with their relationship to reperfusion of the coronary arteries.Ä¿µÄ̽ÌÖ¼±ÐÔÐļ¡¹£Èû»¼ÕßÈÜ˨ǰºóÍâÖÜѪÖÐѪ˨±êÖ¾Îï(D-¶þ¾ÛÌåD-D,Ѫ¹ÜÐÔ¼ÙѪÓѲ¡Òò×ÓvWF)ˮƽ±ä»¯ºÍѪС°å»î»¯×´Ì¬±êÖ¾ÎïѪС°å¦Á¿ÅÁ£Ä¤Ìǵ°°×CD62P¼°ÈÜøÌåĤÌǵ°°×CD63µÄÑôÐÔ±í´ïÂÊÓëѪ¹ÜÔÙͨµÄ¹Øϵ¡£
4)Prethrombotic stateѪ˨ǰ״̬
1.Changes of prethrombotic state in dexes in patients with malignant cancer;¶ñÐÔÖ×Áö»¼ÕßѪ˨ǰ״̬·Ö×Ó±êÖ¾ÎïµÄ±ä»¯
2.Studies and Discussion of of Prethrombotic State In patients with fracture of the lower limbs;ÏÂÖ«¹ÇÕÛÊõºóѪ˨ǰ״̬µÄÑÐÌÖ
3.Effect of telmisartan on prethrombotic state in congestive heart failure;ÌæÃ×ɳ̹¶ÔÂýÐÔÐÄÁ¦Ë¥½ß»¼ÕßѪ˨ǰ״̬µÄÓ°Ïì
5)prothrombotic stateѪ˨ǰ״̬
1.Influences of perindopril on prothrombotic state in elderly hypertensive patients;ÅàßáÆÕÀû¶ÔÀÏÄêÔ­·¢ÐÔ¸ßѪѹ»¼ÕßѪ˨ǰ״̬µÄÓ°Ïì
2.Prothrombotic state and drug interference in elderly hypertensive patients;ÀÏÄêÔ­·¢ÐÔ¸ßѪѹ»¼ÕßѪ˨ǰ״̬¼°Ò©Îï¸ÉÔ¤
3.Study on the relationship between prothrombotic state and the onset patterns of preeclampsia;×ÓüêÇ°ÆÚ·¢²¡ÀàÐÍÓëѪ˨ǰ״̬µÄ¹Øϵ
6)Stateflag״̬±êÖ¾
ÑÓÉìÔĶÁ

¾ÛºÏÎïµÄ·Ö×ÓÁ¿ºÍ·Ö×ÓÁ¿·Ö²¼¾ÛºÏÎïµÄ·Ö×ÓÁ¿ºÍ·Ö×ÓÁ¿·Ö²¼molecular weight and molecular weight distribution of polymers I(M)Öµ¡£·Ö¼¶·½·¨µÄÁíÒ»¸öÈõµãÊÇʵÑé²Ù×÷·Ñʱ¡¢·±¸´£¬ÒÑÖð½¥±»Äý½ºÉ«Æ×·¨ËùÈ¡´ú¡£ ¢Ú³¬ÀëÐijÁ½µ·¨¡£ÔÚ³¬ÀëÐÄ»úµÄ¼¸Ê®Íò±¶µØÐÄÖØÁ¦µÄÀëÐÄÁ¦³¡ÄÚ£¬¿ÉÒÔ¿´µ½¸ß·Ö×ÓÈÜÒºÖеijÁ½µ¶ø·Ö³ö½çÃæ¡£Õâ¸ö½çÃ潫Ëæ³Á½µ¹ý³Ì¶ø±äÃÖÉ¢¡£½çÃæ±ä¿í£¬Ò»·½ÃæÊÇÓÉÓÚÊÔÑùµÄ·Ö×ÓÁ¿·Ö²¼Ôì³ÉµÄ£¬ÒòΪ²»Í¬·Ö×ÓÁ¿µÄ×é·ÖÓв»Í¬µÄ³Á½µËÙÂÊ;ÁíÒ»·½ÃæÊÇÓÉÓÚÓë³Á½µÔ˶¯·½ÏòÏà·´µÄÀ©É¢¹ý³ÌÒýÆðµÄ¡£Í¨¹ýÊʵ±µÄÊý¾Ý´¦Àí£¬¿ÉÒÔ´Ó³Á½µ½çÃæµÄŨ¶È·Ö²¼¼õÈ¥À©É¢±ä¿íÒÔºóµÃµ½ÊÔÑùµÄ³Á½µÏµÊý·Ö²¼W(s)£¬ÔÙͨ¹ý³Á½µÏµÊýÒ»·Ö×ÓÁ¿¹ØϵS(M)£¬¾Í¿ÉËã³öÊÔÑùµÄ·Ö×ÓÁ¿·Ö²¼W(M)¡£ ¢ÛÄý½ºÉ«Æ×·¨¡£Ó¦ÓÃ×î¹ã·ºµÄ·½·¨¡£¶à·ÖÉ¢¸ß·Ö×Ó½ÓÒºÔÚ½øÈëÉ«Æ×Öùºó£¬±»éżÁ°´·Ö×Ó´óС(¼´·Ö×ÓÁ¿´óС)ÁܳöÖùÍâ¡£ÁܳöÒºÓÉ2¸ö¼ì²âÆ÷¼ì²â¡£1¸ö¼ì²âŨ¶È£¬Áí1¸ö¼ì²à·Ö×ÓÁ¿¡£Í¨³£ÓÃʾ²îÕÛ¹â¼Æ¼ì²àŨ¶È£¬ÓÃ×Ô¶¯Õ³¶È¼Æ»ò¹âÉ¢Éä¼Æ¼ì²â·Ö×ÓÁ¿¡£¼Ç¼µÄÇúÏß¼´·Ö×ÓÁ¿·Ö²¼ÇúÏß¡£Ò²¿ÉÒÔÓÃÒÑÖª·Ö×ÓÁ¿Õ­·Ö²¼µÄ±êÑù»òÒÑÖª·Ö×ÓÁ¿µÄ¿í·Ö²¼±êÑù±ê¶¨É«Æ×Öù£¬È»ºó´ÓÁܳöÌå»ýÓë.·Ö×ÓÁ¿µÄ¹Øϵʽ»»Ëã³É·Ö×ÓÁ¿¶øµÃµ½·Ö×ÓÁ¿·Ö²¼ÇúÏß¡£ÓÉÓÚÉ«Æ×ÖùµÄ·ÖÀëЧÂʲ»ÊÇÎÞÏ޵ģ¬ÊµÑéËùµÃµ½µÄÇúÏß½«ÓÉÓÚ¸÷ÖÖÒòËضøÒýÆð·åµÄ¼Ó¿í¡£ÔÚ¾«È·µÄ²âÊÔÖлòÉ«Æ×ÖùÖùЧ½ÏµÍʱ£¬ÐèÒª¿¼ÂÇ·å¼Ó¿í¸ÄÕý¡£ ·Ö×ÓÁ¿ºÍ·Ö×Ó1·Ö²¼¸Õ¶¨µÄÒâÒå·Ö×ÓÁ¿ºÍ·Ö×ÓÁ¿·Ö²¼ÊǸ߷Ö×Ó²ÄÁϵĻù´¡½á¹¹²ÎÊý£¬Óë¾ÛºÏ¹ý³ÌºÍ²ÄÁϵļӹ¤ÐÔÄÜÒÔ¼°Ê¹ÓÃÐÔÄÜÓÐÃÜÇйØϵ¡£¾ÛºÏÎïµÄ¼Ó¹¤¹ý³Ì£¬ÈçÈÚÈÛ·ÄË¿¡¢Ä£Ñ¹¡¢ÍùËܳÉÐͺʹµËܳÉĤµÈ£¬¶¼Éæ¼°¾ÛºÏÎïÈÛÌå»ò±¾ÌåµÄÁ÷±äÐÔÖÊ¡£ÆäÖÐÕ³¶ÈºÍµ¯ÐÔ(¿É»Ø¸´Ðαä)¶¼ÓÐÇ¿ÁҵķÖ×ÓÁ¿ÒÀÀµÐÔ¡£ÀýÈçµÍÇбäËÙ¶ÈϵÄÈÛÌåÕ³¶ÈºÍ£¬ÔÚÒ»¶¨·Ö×ÓÁ¿ÒÔÉϽ«Õý±ÈÓÚ·Ö×ÓÁ¿µÄ3 .4´Î·½;±íÕ÷ÈÛÌ嵯ÐԵĵÚÒ»·¨ÏòÓ¦Á¦²îÒ²Õý±ÈÓÚ·Ö×ÓÁ¿µÄ7Ò»8´Î·½¡£¸ß·Ö×ÓÁ¿µÄÈÛÌåÕ³¶È»¹ÓÐÇ¿ÁҵķÇÅ£¶ÙÐÔµÄÇбäËÙ¶ÈÒÀÀµÐÔ¡£·Ö×ÓÁ¿Óë½»Áª¹ý³ÌÒ²ÓÐÒ»¶¨¹Øϵ¡£¾ÛºÏÎïµÄʹÓÃÐÔÄÜ£¬ËäÈ»Ö÷Òª¾ö¶¨ÓÚ¾ÛºÏÎïµÄÄý¾Û̬½á¹¹£¬µ«ÊÇ·Ö×ÓÁ´µÄÈ¡Ïò¡¢³ÚÔ¥¹ý³ÌºÍ½á¾§¹ý³Ì¶¼ÏÔÖøÒÀÀµÓÚ·Ö×ÓÁ¿¡£ÒòÃæºê¹ÛµÄʹÓÃÐÔÄÜ£¬È翹ÕÅÇ¿¶È¡¢¶ÏÁÑÉ쳤¡¢ÑïÊÏÄ£Á¿¡®Ó²¶È¡¢³å»÷Ç¿¶È¡¢Èí»¯Î¶ȡ¢ÔÚÈܼÁÖеÄÈܽâ¶È¡¢Õ³½ÓÐÔÄܶ¼ÓзÖ×ÓÁ¿ºÍ·Ö×ÓÁ¿·Ö²¼µÄÒÀÀµÐÔ¡£³ý×îºóÁ½ÏîÐÔÄÜÍ⣬ËùÓÐÐÔÄܶ¼Ëæ·Ö×ÓÁ¿µÄÔö´ó¶øÔö´ó£¬µ«·Ö×ÓÁ¿µ½´ïÒ»¶¨ÊýÖµºóÆäÔöÁ¿½«Ç÷ƽ»º¡£Ò»¸ö¸ß·Ö×Ó²ÄÁÏÊÔÑùÖÐËù°üº¬µÄÐí¶à¸ß·Ö×Ó£¬ËüÃǵķÖ×ÓÁ¿¿ÉÒÔ²»Ïàͬ¡£ÕâÖÖ·Ö×ÓÁ¿µÄ²»¾ùÒ»ÐÔ³ÆΪ·Ö×ÓÁ¿¶à·ÖÉ¢ÐÔ¡£Òò¶ø£¬¶ÔÒ»¸öÊÔÑùÀ´Ëµ£¬ËüµÄ·Ö×ÓÁ¿ÓÐÒ»¸ö·Ö²¼£¬ÓÃÒ»°ã·Ö×ÓÁ¿²â¶¨·½·¨ËùµÃµÄÖ»ÊÇÒ»¸öƽ¾ùÖµ¡£ ¾ÛºÏÎï·Ö×Óͯ·Ö²¼ºÍƽ¾ù·Ö×Óͯ·Ö×ÓÁ¿¶à·ÖÉ¢µÄÌåϵ¿ÉÒÔÓ÷ֲ¼º¯Êý±íʾ¡£